Drug intelligence / Profile preview

eucommia ulmoides + glycyrrhiza uralensis

Development stage
Preclinical
Lead developer
Zhejiang Chinese Medical University
Modality
Small Molecules
Administration
Oral
01

Overview

*Eucommia ulmoides + Glycyrrhiza uralensis* is a traditional Chinese medicine (TCM) herbal combination, commonly known as the EG couplet medicine. It is primarily studied for its **chondroprotective effects** and potential benefits in treating **knee osteoarthritis (KOA)**. Mechanistically, EG has been shown in preclinical models to protect articular cartilage by promoting extracellular matrix synthesis (elevating Col2 and Aggrecan), reducing matrix degradation (inhibiting MMP13 and Adamts5), and modulating inflammation. Network pharmacology and experimental data suggest the principal mechanism involves **upregulating peroxisome proliferator-activated receptor gamma (PPARG)**. *Eucommia ulmoides* is traditionally used to "strengthen muscles and bones," while *Glycyrrhiza uralensis* (licorice root) has recognized anti-inflammatory effects. The combination exhibits synergistic properties, possibly through interactions that prolong the release and activity of herbal constituents. Both herbs are also associated with cardiovascular and anti-bleeding profiles when used with anticoagulant therapy, but their main investigated TCM use remains in musculoskeletal and inflammatory conditions[1][3][2].

Other names
EGE.G. couplet medicine
02

Targets

COL2 (Type II Collagen)MMP13 (Matrix metalloproteinase-13)ACAN (Aggrecan core protein)ADAMTS5 (A disintegrin and metalloproteinase with thrombospondin motifs 5)

Beyond the preview

Go deeper on eucommia ulmoides + glycyrrhiza uralensis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eucommia ulmoides + glycyrrhiza uralensis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call